Skip to Content
Merck
CN
  • Release, partitioning, and conjugation stability of doxorubicin in polymer micelles determined by mechanistic modeling.

Release, partitioning, and conjugation stability of doxorubicin in polymer micelles determined by mechanistic modeling.

Pharmaceutical research (2014-11-20)
Andrei Ponta, Kyle D Fugit, Bradley D Anderson, Younsoo Bae
ABSTRACT

To better understand the mechanistic parameters that govern drug release from polymer micelles with acid-labile linkers. A mathematical model was developed to describe drug release from block copolymer micelles composed of a poly(ethylene glycol) shell and a poly(aspartate) core, modified with drug binding linkers for pH-controlled release [hydrazide (HYD), aminobenzoate-hydrazide (ABZ), or glycine-hydrazide (GLY)]. Doxorubicin (Dox) was conjugated to the block copolymers through acid-labile hydrazone bonds. The polymer drug conjugates were used to prepare three polymer micelles (HYD-M, ABZ-M, and GLY-M). Drug release studies were performed to identify the factors governing pH-sensitive release of Dox. The effect of prolonged storage of copolymer material on release kinetics was also observed. Biphasic drug release kinetics were observed for all three micelle formulations. The developed model was able to quantify observed release kinetics upon the inclusion of terms for unconjugated Dox and two populations of conjugated Dox. Micelle/water partitioning of Dox was also incorporated into the model and found significant in all micelles under neutral conditions but reduced under acidic conditions. The drug binding linker played a major role in drug release as the extent of Dox release at specific time intervals was greater at pH 5.0 than at pH 7.4 (HYD-M > ABZ-M > GLY-M). Mathematical modeling was also able to correlate changes in release kinetics with the instability of the hydrazone conjugation of Dox during prolonged storage. These results illustrate the potential utility of mechanistic modeling to better assess release characteristics intrinsic to a particular drug/nanoparticle system.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Potassium hydrogen phthalate, BioXtra, ≥99.95%
Supelco
Monobasic Potassium Phosphate, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Monobasic potassium phosphate, United States Pharmacopeia (USP) Reference Standard
Supelco
Potassium phthalate monobasic, reference material for titrimetry, certified by BAM, >99.5%
Supelco
Potassium phthalate monobasic, qNMR standard, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Potassium phosphate monobasic, meets analytical specification of Ph. Eur., NF, E340, anhydrous, 98-100.5% (calc. to the dried substance)
Sigma-Aldrich
Potassium phthalate monobasic, ACS reagent, acidimetric standard
Sigma-Aldrich
Potassium phosphate monobasic, 99.99% trace metals basis
Sigma-Aldrich
Potassium phosphate monobasic, powder, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99.0%
Sigma-Aldrich
Potassium phthalate monobasic, puriss. p.a., ≥99.5% (T)
Sigma-Aldrich
Potassium phosphate monobasic, ACS reagent, ≥99.0%
Sigma-Aldrich
Potassium phosphate monobasic, ReagentPlus®
Sigma-Aldrich
Potassium phthalate monobasic, BioUltra, ≥99.5% (T)
Sigma-Aldrich
Potassium phosphate monobasic, BioUltra, Molecular Biology, anhydrous, ≥99.5% (T)
Sigma-Aldrich
Potassium phosphate monobasic, tested according to Ph. Eur., anhydrous
Sigma-Aldrich
Potassium phosphate monobasic, buffer substance, anhydrous, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 99.5-100.5%
Sigma-Aldrich
Potassium phosphate monobasic, Molecular Biology, ≥98.0%
Sigma-Aldrich
Potassium phosphate monobasic, Vetec, reagent grade, 99%
Sigma-Aldrich
Potassium phthalate monobasic, Vetec, reagent grade, 99%